Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Applied Optics
|
August 25, 2010
Reflection display holograms on dichromated gelatin
R D Bahuguna, J Beaulieu, H Arteaga
International Journal of Obesity
|
January 1, 1982
Obesity among schoolchildren of different socioeconomic levels in a developing country
H Arteaga, J E Dos Santos, J E Dutra de Oliveira
L'Encephale
|
September 23, 2019
The clinical and economic impact of three-monthly long-acting formulation of paliperidone palmitate versus the one-monthly formulation in the treatment of schizophrenia in France: A cost-utility study
C H Arteaga Duarte, E Fakra, C Van Gils, et al.
Cost Effectiveness and Resource Allocation : C/E
|
February 25, 2025
Cost-effectiveness of nirmatrelvir/ritonavir in COVID-19 patient groups at high risk for progression to severe COVID-19 in the Netherlands
Carlos H Arteaga Duarte, Michel L Peters, Michelle H M de Goeij, et al.
Applied Health Economics and Health Policy
|
July 17, 2022
Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers
Renée E Michels, Carlos H Arteaga, Michel L Peters, et al.
Rheumatology and Therapy
|
January 12, 2023
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons
Nurullah Akkoç, Carlos H Arteaga, Simone E Auteri, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Applied Optics
|
August 25, 2010
Reflection display holograms on dichromated gelatin
R D Bahuguna, J Beaulieu, H Arteaga
International Journal of Obesity
|
January 1, 1982
Obesity among schoolchildren of different socioeconomic levels in a developing country
H Arteaga, J E Dos Santos, J E Dutra de Oliveira
L'Encephale
|
September 23, 2019
The clinical and economic impact of three-monthly long-acting formulation of paliperidone palmitate versus the one-monthly formulation in the treatment of schizophrenia in France: A cost-utility study
C H Arteaga Duarte, E Fakra, C Van Gils, et al.
Cost Effectiveness and Resource Allocation : C/E
|
February 25, 2025
Cost-effectiveness of nirmatrelvir/ritonavir in COVID-19 patient groups at high risk for progression to severe COVID-19 in the Netherlands
Carlos H Arteaga Duarte, Michel L Peters, Michelle H M de Goeij, et al.
Applied Health Economics and Health Policy
|
July 17, 2022
Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers
Renée E Michels, Carlos H Arteaga, Michel L Peters, et al.
Rheumatology and Therapy
|
January 12, 2023
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons
Nurullah Akkoç, Carlos H Arteaga, Simone E Auteri, et al.
Page
of 1